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ABSTRACT
 
Multidimensional Characterization of Thermally Actuated Shape Memory Polymer 
Neurovascular Stents. (May 2012) 
 
Landon D. Nash 
Department of Biomedical Engineering 
Texas A&M University 
 
Research Advisor: Dr. Duncan J. Maitland 
Department of Biomedical Engineering 
 
In this work, shape memory polymer neurovascular stent prototypes based on a 
previously proposed design were thermo-mechanically characterized to expand on the 
clinical efficacy of the device. The stents were made by dip-coating pins in a 
thermoplastic polymer solution and subsequently covalently crosslinking the polymer 
using UV irradiation to yield thermoset tubes. These crosslinked tubes were CO2 laser 
engraved to produce the complex stent geometry.  
  
Experiments were conducted to determine the physiologically relevant mechanical 
behavior of these devices. Three point bend tests were performed to determine the 
longitudinal flexibility of deployed stents at room temperature and body temperature. 
The resulting longitudinal flexibility data was compared to currently available stent 
systems. Radial behavior tests were conducted on stent prototypes and polymer tubes 
using a radial compression system that interfaces with a tensile tester. Crimping and 
radial recovery behavior experiments measured the pressure exerted by the device as a 
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function of strain recovery at discrete temperatures. Crimped polymer tubes, 
representing idealized polymer stents, were deployed in the compression station at fixed 
diameters. These tests represented the constrained recovery environment of an occluded 
vessel and quantified recovery pressures as a function of temperature. Material 
characterization techniques such as dynamic mechanical analysis, tensile testing, and gel 
fraction studies were employed to further quantify the clinical relevance of this device.  
 
These devices proved to have longitudinal flexibility values comparable to or better than 
many stents currently available on the market, which makes them attractive for 
neurovascular applications requiring navigation of tortuous vessels. Additionally, shape 
memory tests demonstrated a one second device deployment, which minimizes the 
amount of heat introduced into the body. This study also provides a body of data useful 
for further optimization of this medical device, such as desirable crimping pressures, 
optimal crimping temperatures, and device deployment pressures. 
 
  
  v 
DEDICATION 
 
I dedicate this thesis to my mother. She is the foundation of my amazing family, and I 
love her dearly. 
  vi 
ACKNOWLEDGMENTS 
 
This thesis would not have been possible without the help, insight, and advice of several 
people that I respect very highly.  
 
I’d like to thank Dr. Duncan Maitland for the opportunity to work in his lab. His advice 
and the experience that I have gained working for him have been the most valuable 
aspects of my undergraduate career.  He is an exceptional advisor. 
 
Thanks to my mentor Brent Volk for his guidance and advice throughout the course of 
this project. He is one of the most genuinely nice, humble, but brilliant people I’ve had 
the pleasure of meeting. 
 
Thanks to Keith Hearon for teaching me how to conduct research, properly make sweet 
tea, showing me the ins and outs of plastic, clarifying that Texas is definitely not part of 
the South, and most of all for giving sound life advice that comes from experience. 
You’re a great friend. 
 
I would have no molecular weight data if it weren’t for the help of Alex Lonnecker from 
Dr. Karen Wooley’s group in the Chemistry Department at Texas A&M. Thank you for 
making the method and running my samples. 
 
  vii 
Finally I would like to thank my loving family for their infinite support, particularly my 
parents. You’ve all set a great example for me. 
  viii 
NOMENCLATURE 
 
2-but 2-butene-1,4-diol 
AA Allyl Alcohol 
DMA Dynamic Mechanical Analysis 
DMPA 2,2-Dimethoxy-2-phenyl-acetophenone  
FDA Food and Drug Administration 
PSI Pounds Per Square Inch 
PU Polyurethane 
SEC Size Exclusion Chromatography 
SMP Shape Memory Polymer 
Tg Glass Transition Temperature 
THF Tetrahydrofuran 
TRF Total Radial Force 
TMHDI Trimethylhexamethylene diisocyanate 
UV Ultraviolet 
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CHAPTER I 
INTRODUCTION 
 
The focus of this work is to characterize the thermo-mechanical behavior of thermally 
actuated, amorphous, covalently crosslinked shape memory polymers (SMPs), which 
recover from a temporary shape to a primary shape when heat is applied. This shape 
memory property makes these materials attractive for a wide variety of biomedical 
applications1-3, including minimally invasive endovascular interventions4-7. 
 
Clinical motivation 
In the United States, a person has a stroke approximately every 40 seconds8. Current 
stroke intervention procedures such as aneurysm coiling and carotid artery stenting 
display clinical success in treating stroke, but there is still a need for better therapies. 
There is a particularly large clinical gap in the treatment of ischemic stroke due to 
intracranial atherosclerosis9. Ischemic strokes account for 87% of all total strokes, and 
10% of these events are attributed to intracranial atherosclerosis8. Angioplasty and 
subsequent stenting of atherosclerotic neurovasculature are available to treat the risk of 
ischemic stroke in patients that are unresponsive to alternative therapies like 
anticoagulation medications and blood pressure/cholesterol therapies. Intracranial 
angioplasty and stenting are only performed on high-risk patients as a last resort because 
neurovascular stents have only received humanitarian device exemption from the Food 
_______________ 
This thesis follows the style of Journal of Applied Polymer Science. 
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and Drug Administration (FDA)9 due to limited success in clinical trials.  
 
The current standard for treating endovascular diseases, including different types of 
atherosclerosis and coronary artery disease, are catheter-based stents. The current FDA 
approved stents are metallic and have evolved from bare metal stents to more advanced 
stents, some of which have drug eluting polymeric coatings10. Despite the success of 
current stent designs, they still have drawbacks. For example, these devices are no 
longer needed after the healing and remodeling of the vessel in which they are deployed. 
The permanent nature of traditional bare metal stents is a detriment, causing prolonged 
irritation and inflammation of the vessel that can lead to restenosis11, 12. Drug eluting 
stents were developed to help alleviate the problem of restenosis, but delayed healing 
due to polymeric coatings increases the chance of late thrombosis13. Another drawback 
of metal stents is that they can interfere and create artifacts when using imaging 
modalities such as magnetic resonance imaging (MRI) and computed tomography 
(CT)14, 15. Finally, the permanence of metal stents prevents further interventions on the 
same vessel and restricts natural vasomotion. 
 
Metal stent drawbacks have motivated research in biodegradable polymeric stents16, 17. 
Polymer stents offer solutions to many of the problems associated with traditional metal 
stents. Biodegradation, for which the polymer chemistry can be tailored, after vessel 
remodeling and initial healing allows the vessel to completely endothelialize, restore its 
natural vasomotion, decreases the risk of late thrombosis, and allows for further 
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intervention on the diseased vessel or downstream vessels if necessary12. A predominant 
criticism of polymer stents is that they have inferior mechanical properties when 
compared to their metal counterparts due to polymers typically having a modulus that is 
three to six orders of magnitude lower than metals depending on if the polymer is in its 
glassy or rubbery state. However, studies have shown that polymer stents with modified 
geometries can achieve a structural response comparable to metal stents17, 18, and other 
studies suggest that a lower modulus material may actually be more beneficial due to 
better compliance matching with the vessel wall19. These stents have potential in all 
areas where stents are currently used, but are particularly interesting for neurovascular 
applications due to their flexibility. Devices made of flexible low modulus materials will 
be able to navigate the tortuous vasculature of the brain easier. However, polymer stents 
are not without limitations. For instance, degradation products from biodegradable 
polymers such as poly-l-lactic acid can produce an acidic environment that causes 
prolonged inflammation20. Additionally, polymer stents must be designed with thicker 
strut geometries to achieve radial expansion forces comparable to metal stents. These 
thicker cross-sections limit the strains the devices can withstand21. Another inherent 
drawback of polymer devices is that polymers are not radio-opaque without 
modifications. The lack of radio-opacity can be alleviated with techniques such as 
adding radio opaque markers (e.g. gold16) or doping with tungsten21. These drawbacks 
require the optimization of polymer chemistries to have appropriate degradation times, 
biocompatibility, and mechanical properties. This study focuses on material mechanical 
properties and how they relate to device performance. 
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Shape memory polymers (SMPs) are relatively new materials that are attractive for 
medical devices, particularly stents4-7, 22. These materials can change their geometry 
when exposed to an external stimulus. This shape recovery can be induced in several 
ways (e.g. pH, electricity, heat), but this study focuses on thermal stimulation. Instead of 
elastic recoil, these devices return to their primary shape due to an entropy-driven 
process. This shape memory effect arises from netpoints (physical or chemical 
crosslinks) that remember the primary geometry and switching segments (amorphous or 
crystalline polymer regions) that can be “programmed” into a metastable secondary 
geometry. Amorphous switching segments actuate around a glass transition temperature 
(Tg), while crystalline switching segments actuate according to the melt transition 
temperature (Tm). The materials in this study are chemically crosslinked amorphous 
SMPs that actuate at Tg. Figure 1 portrays one thermal shape memory cycle. The cycle 
starts with the polymer in its primary shape. The polymer is fabricated in this geometry, 
and it is the lowest energy state because the polymer chains are highly coiled and 
randomly configured (max entropy state). When the material is heated above Tg, the 
amorphous polymer chains in the material loosen and are easily deformed. When the 
ribbon is deformed into the spiral geometry shown, the polymer chains within the 
material uncoil and become more aligned. This is a higher energy state because there is a 
decrease in entropy. Cooling the material below Tg while maintaining the load locks this 
secondary geometry. Below Tg, the polymer chains are not flexible enough to return to 
the max entropy state. Thus, potential energy is stored in the form of an “entropic 
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spring.” In the last step of the cycle, the polymer chains coil when the material is heated 
above Tg, releasing the stored energy and returning the polymer to its primary geometry. 
 
 
Figure 1 An idealization of one shape memory cycle of a shape memory polymer ribbon. This ribbon can 
be deformed when the temperature is above Tg, then cooled to below Tg to fix the secondary shape. 
Potential energy is stored at this step in the form of an “entropic spring.” When the material is heated 
above Tg, this energy is released and the material returns to its primary shape. 
 
 
Shape memory polymers can be heated by a variety of methods including laser light5, 
magnetic induction23, resistive heating, and body heat. These materials are useful for 
stent design because it allows them to be crimped to a small geometry and deployed via 
a controlled stimulus. This delivery method eliminates the need for balloon catheter 
device delivery, which can potentially overinflate and cause damage to the vessel10.  
 
Research objective 
This study will expand on the clinical efficacy of a previously proposed SMP stent 
design18 by characterizing its recovery behavior and quantifying the longitudinal 
flexibility of the device by performing three point bend tests, the results of which will be 
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compared to data from numerous stent systems that have been compiled and published24. 
This SMP stent design capitalizes on the flexibility of polymer devices in an effort to 
bridge the clinical gap for treating intracranial atherosclerosis.  This flexible design is 
proposed to navigate tortuous neurovasculature, and has a collapse pressures comparable 
to current neurovascular stents18. 
 
A novel polyurethane shape memory polymer system developed by Keith Hearon will be 
used to achieve the complex geometry of the proposed stent design. This novel SMP 
system enables the fabrication of devices with the desired shape memory properties of 
thermosets using the superior processing capabilities of thermoplastics. One major 
advantage of thermoplastic polymers is in the area of processing. Thermoplastic 
polymers contain physical crosslinks such as hydrogen bonding and van der Waals 
forces. These physical interactions can be interrupted with elevated temperatures or a 
proper solvent, causing the polymer to flow. Thus thermoplastics can be easily processed 
into complex geometries using techniques such as heat extrusion and solution casting. 
On the other hand, covalently crosslinked thermoset polymers, whose mesh-like 
molecular structure resembles that of a fishing net, neither flow at elevated temperatures 
nor dissolve in solvents and are therefore subject to numerous processing limitations.  
However, covalent crosslinking can enhance certain mechanical properties, including 
higher failure stresses and better shape memory properties, and certain applications 
demand the enhanced mechanical advantages of thermoset materials.  The novel SMP 
system used for stent fabrication in this study can be solution cast into a desired 
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geometry as a thermoplastic and subsequently crosslinked in a secondary step.   In this 
SMP system, outlined in figure 2, thermoplastic polymers are solution blended with 
proprietary crosslinker monomers. These thermoplastic/crosslinker blends are 
subsequently subjected to ultraviolet (UV) radiation in the presence of photoinitiator to 
enable the formation of covalent crosslinks between the polymer chains. This process 
facilitates the construction of a complex thermoplastic geometry and the subsequent UV 
crosslinking to yield a final thermoset device. 
 
 
Figure 2 A thermoplastic polymer with a reactive double bond in the backbone is solution blended with a 
proprietary polyfunctional crosslinker. The polymer has significant processing flexibility at this point. 
Once the device geometry is made, the polymer is covalently crosslinked using ultraviolet radiation to 
initiate the crosslinking reaction. 
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This polymer system also allows for highly tailored mechanical properties, 
demonstrating independent control of Tg and rubbery modulus by altering the chemistry 
composition. Other benefits of this polymer system are sharp glass transitions and high 
rubbery moduli, which translate to fast shape recovery and higher recovery forces, 
respectively. This chemistry could be manipulated to be biodegradable, and post-
processing techniques could be employed to make this material radio-opaque; however, 
both of these material aspects are outside the scope of this study. 
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CHAPTER II 
METHODS 
 
This study started with synthesizing thermoplastic urethanes. These polymers were used 
to identify a chemistry that was reproducible and compatible with a dip-coat processing 
technique. Polymer molecular weight, proprietary crosslinker percentage, and 
crosslinker chemistry were varied in thermoset film syntheses to find a functional 
material composition. Stents of varying wall thickness were made with a single chosen 
composition, and these devices were thermo-mechanically characterized with 
longitudinal flexibility and radial expansion tests. 
 
Thermoplastic polymer synthesis 
All chemicals, unless otherwise stated, were purchased from TCI America and used as 
received. Thermoplastic polyurethanes were synthesized from 2-butene-1,4-diol (2-but) 
and trimethylhexamethylene diisocyanate (TMHDI) in 33 wt% anhydrous  
tetrahydrofuran (THF) solutions in flame dried 8 oz glass jars using a 1 mole % 
stoichiometric diisocyanate excess. Figure 3 shows the polymerization reaction and 
resulting polymer repeat unit. 
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Figure 3 Trimethylhexamethylene diisocyanate and 2-butene-1,4-diol were polymerized in 33 wt% THF 
solution to yield polyurethane repeat units containing reactive double bonds. 
 
 
 
All syntheses were conducted in 100 gram batches in the presence of 0.01 weight 
percent Zirconium(IV) 2,4-pentanedionate catalyst. The monomers were stored and 
mixed in a moisture-free environment using a LabConco glove box.  All reactants, 
solvents, and catalysts were mixed in flame dried 240 mL glass jars, and 30 grams of 3 
Å molecular sieves, purchased from Sigma Aldrich, were added to further reduce 
moisture content. To control the molecular weights of the polymers, allyl alcohol (AA) 
was substituted for the 2-but monomer in 1, 3, and 5 mole % quantities to serve as a 
monofunctional chain terminating agent. All polymerizations were carried out at 80°C 
for 24 hours at 120 RPM vortex speed using a Labconco RapidVap apparatus. After the 
polymerizations, the THF/polymer solutions were diluted to 10 wt % and were separated 
from the molecular sieves by filtration through VWR grade 490 filter paper. The filtered 
dilute solutions were then poured into 22 x 30 cm polypropylene dishes for solvent 
removal. The polypropylene dishes were left at ambient temperature and pressure in a 
fume hood for 12 hours, after which they were heated to 80°C for 24 hours, after which 
they were subjected to evacuation at 1 torr at 80°C for an additional 24 hours. After 
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solvent removal, clear thermoplastic polyurethane films were removed from the 
polypropylene dishes. 
 
Size exclusion chromatography 
Size exclusion chromatography (SEC) was conducted to quantify the molecular weights 
of the resulting polymerizations. SEC was conducted on a Waters 1515 HPLC equipped 
with a Waters 2414 differential refractometer, Waters 2998 photodiode array detector, 
and a three column series of PL gel 5 µm mixed C, 500 Å, and 104 Å (300 × 7.5 mm) 
columns. The system was equilibrated at 35°C in N,N-dimethylformamide, which served 
as the polymer solvent and eluent with a flow rate of 1.0 mL/min. Polymer solutions 
were prepared at a known concentration (ca. 3 mg/mL), and an injection volume of 200 
µL was used. In addition, the differential refractometer was calibrated with standard 
polystyrene reference material (SRM 706 NIST), of which the specific refractive index 
increment dn/dc is known (0.184 mL/g). The differential refractometer response was 
used to determine the dn/dc values of the analyzed polymers. Single samples of 
thermoplastic PUs with 0%, 1%, 3%, and 5% allyl alcohol content were run. 
 
Thermoset film fabrication 
Thermoset films were fabricated by solution blending 3.33 g of the thermoplastics 
containing varying allyl alcohol content with varying amounts of the proprietary 
crosslinkers, Crosslinker A and Crosslinker B, in 15 wt% THF solutions. These samples 
were made to identify a chemistry that was stable in solution at high concentrations 
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because initial stent fabrication efforts yielded phase separated material. Table 1 outlines 
the composition of each series. The crosslinker percentages refer to the ratio of moles 
crosslinker reactive sites to moles of C=C groups in the thermoplastics (provided the 
information that one proprietary crosslinker reactive group reacts with one C=C group).  
Three wt % of the photo initiator 2,2-Dimethoxy-2-phenyl-acetophenone (DMPA) was 
used for every solution to ensure sufficient crosslinking.  
 
TABLE I 
Summary of Thermoset Film Compositions Varying Crosslinker Chemistry and 
Concentration With Varying Allyl Alcohol Content Thermoplastic Polymer 
Series	  
Number	   Sample	   Allyl	  Alcohol	  Content	   Crosslinker	  A	  Content	   Crosslinker	  B	  Content	  
1	  
A	   0%	   100%	   0%	  
B	   1%	   100%	   0%	  
C	   3%	   100%	   0%	  
D	   5%	   100%	   0%	  
2	  
A	   0%	   0%	   100%	  
B	   1%	   0%	   100%	  
C	   3%	   0%	   100%	  
D	   5%	   0%	   100%	  
3	  
A	   5%	   25%	   0%	  
B	   5%	   50%	   0%	  
C	   5%	   75%	   0%	  
D	   5%	   100%	   0%	  
4	  
A	   5%	   0%	   20%	  
B	   5%	   0%	   40%	  
C	   5%	   0%	   60%	  
D	   5%	   0%	   80%	  
E	   5%	   0%	   100%	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Solutions containing thermoplastic polymer, crosslinker, and photoinitiator were poured 
into 5 x 5 cm reservoirs in 12-compartment polypropylene boxes purchased from 
McMaster-Carr. Films were cast by allowing solvent to evaporate for 24 h at ambient 
temperature in a fume hood. The films were subsequently crosslinked for 45 minutes in a 
UV crosslinker (UltraViolet Products) at a wavelength of 365 nm. The films were 
transferred into aluminum trays and post-cured at 120 °C under vacuum for 2 hours. The 
optical clarity of each film was observed for signs of phase separation. The clearest 
sample chemistries were chosen for further quantification of homogeneity and thermo-
mechanical behavior. 
 
Dynamic mechanical analysis (DMA) 
The thermoset films were cut into thin rectangular DMA samples (approximately 
4.75mm x 32mm) using a Gravograph LS100 CO2 laser engraving system. Dynamic 
mechanical analysis of these samples was performed in tension using a TA Q800. Tests 
were conducted using the multi-frequency strain mode with a preload force of 0.01 N. 
Samples were equilibrated at 0°C, held isothermal for 10 min, and temperature was 
ramped from 0°C to 120°C at 1°C/min. The measured dynamic material properties (i.e. 
storage modulus, loss modulus, and tan delta) were plotted as a function of temperature. 
These plots were analyzed to determine glassy modulus, rubbery modulus, and Tg as 
defined by the tan delta peak. 
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Tensile testing 
Strain to failure tests were conducted on an Instron 5965 test frame with an accessory 
Eurotherm temperature chamber and video extensometer for measuring strain. Solution 
cast thermoset films were cut into ASTM D638 Type V dogbones using the LS100 CO2 
laser. Each sample was sanded with 400 grain sand paper to remove surface defects. The 
samples were strained to material failure at a rate of 50 mm/min at the tan delta peak 
temperature as determined by DMA. 
 
Shape memory tests 
Two types of tensile shape memory tests were attempted to acquire material properties 
that would be necessary to calibrate a computational SMP model. The tensile tests were 
modeled after those conducted by Volk et al25. Unfortunately these methods did not 
work for thin dip-coated tensile samples. These tests will need to be expanded in the 
future to get consistent results. A third shape memory test was conducted to prove the 
shape memory properties of the stent prototypes. 
 
Tensile constrained recovery tests 
In this test, material is heated above Tg, stretched to a fixed strain, cooled below Tg, and 
unloaded to fix the elongated secondary geometry. The sample is then re-gripped at a 
fixed strain and heated above Tg to measure the stress the material exerts during shape 
recovery as a function of temperature. To accomplish this, Type V dogbone samples 
were gripped in the top grip of an Instron 5965 test frame and equilibrated at 80°C for 15 
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minutes. This temperature was chosen because it is well within the rubbery plateau of 
the material. After reaching thermal equilibrium and zeroing the load cell, the bottom of 
the sample was gripped. Samples were strained to 25% as measured by a video 
extensometer and subsequently cooled, maintaining the 25% strain, to 20°C at a rate of 
1°C/min. The samples were unloaded to zero stress. This relieved any internal stresses 
due to thermal expansion during the test, but the material still remained in its elongated 
secondary shape because it was below Tg when it was unloaded. The sample was re-
gripped, and recovery stress was measured while the samples were held at constant 
strain and the temperature was ramped back to 80°C at 1°C/min. A plot of stress as a 
function of temperature was generated to determine the recovery stress of the material. 
 
Tensile free recovery tests 
This test is similar to the constrained recovery tests, but after the material is programmed 
into its secondary geometry, the sample is allowed to hang freely as it is heated above 
Tg. This test quantifies the amount of strain a shape memory material can recover. The 
free recovery tests followed the same method as the constrained recovery tests up thru 
when the samples were unloaded to zero stress. At this point, the bottom grip was 
released to ensure zero applied load on the sample. Strain recovery was measured by the 
video extensometer while the temperature was ramped back to 80°C at 1°C/min. Plots of 
strain recovery as a function of temperature were generated to determine the amount of 
the applied strain that was recovered. 
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Stent fabrication 
Stents of a complex geometry were made using a dip-coating procedure.  First, 
cylindrical pins were dip-coated in a polymer solution and then machined into a complex 
geometry using a CO2 laser. 
 
Dip-coat solution 
The dip-coat solutions were prepared in 60 mL glass vials by dissolving 22 g of the 5% 
AA thermoplastic polyurethane in 27 g THF. This concentration of polymer and solvent 
was qualitatively optimized in multiple dip-coating trials to achieve desirable viscosity 
and volume for dip coating. To match the dip-coat solution to the chosen chemistry from 
the thermoset film trials, Crosslinker A was added to the solution to make a 2:1 mole 
ratio of polymer double bonds to crosslinker reactive site functionalities. Since the 
reduced molecular weight thermoplastic PUs are telechelic, the double bonds from the 
allyl alcohol chain ends were accounted for in the stoichiometry. Three weight percent 
DMPA was added to the polymer solutions after thermoplastic dissolution.  After 
photoinitiator addition, all solutions were wrapped in aluminum foil to minimize 
exposure to ambient light. 
 
Dip-coating 
Brass pins measuring 4 mm in diameter were cut into 80mm lengths. These pins were 
mounted in a drill press and sanded to a smooth, tarnish-free finish using 400 and 2000 
grit sandpaper. To ensure the material would release from the pin, a thin coat of Teflon 
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mold release spray was added to each pin.  The spray was then sintered to the pin using a 
handheld butane torch. As shown in Figure 4, a group of four pins were mounted on a 
custom fixture for dip-coating and then dipped, using a linear translating platform, into 
the polymer solution over a 51 mm range at a rate of 0.67 mm/sec. The pins were held at 
the bottom of the dip for 20 seconds, and removed from the solution at the same rate. 
Before applying another dip-coating layer, the pin fixtures were placed in an oven at 45 
˚C for 20 minutes to promote solvent evaporation. The dipping process was repeated 6 to 
10 times to vary the wall thickness of the polymer tubes between 140-220 microns. 
 
 
Figure 4 Dip-coating setup shown at the top of the dip. The ends of the pins are just above the surface of 
the polymer solution. 
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In addition to pins, flat brass bars measuring 3 x 80 x 12 mm were dip-coated to yield 
flat films with the same thickness and processing history as the stent material. These 
were used to make DMA and tensile samples because they are more representative of the 
stent material. The solution cast thermoset films proved to have different mechanical 
properties, which will be covered in the discussion. 
 
Processing 
After dip-coating, the pins were left in darkness for 24 hours to allow further solvent 
evaporation. Allowing for some solvent evaporation reduces the amount of material 
shrink during the post cure, which minimizes material splitting. However, leaving the 
pins at ambient conditions for too long (multiple days) can lead to phase separation of 
the blended crosslinker. The pins were crosslinked for 45 minutes in a UV crosslinking 
chamber at a wavelength of 365 nm. Figure 5 outlines the crosslinking mechanism of the 
stent material composition.  
 
 
 
Figure 5 Crosslinking chemistry outline. The dip-coated thermoplastic polymer material is solution 
blended with polyfunctional Crosslinker A in a 0.5:1 A : C=C ratio. The photoinitiator DMPA is also 
solution blended at 3 wt% to initiate polymer crosslinking. 
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As shown in figure 6, the final crosslinked material was then cut into solid rings as well 
as complex stent geometries using a LS100 CO2 laser equipped with a cylindrical 
engraving attachment. The stent pattern was made using SolidWorks 2011 and saved as 
an .ai file type. Using Adobe Illustrator, this file was converted to an .eps file, which is 
compatible with the LS 100 Gravostyle software. After engraving, the material was post 
cured on the brass pins at 120˚C for 2 hours under vacuum to remove residual solvent. 
Finally, the stents were carefully removed by hand from their brass dip coating pins. All 
thermoplastic polymers, thermoset films, stents, and tubes were kept in sealed containers 
that contained desiccant rocks to prevent moisture uptake. Water plasticizes thermoset 
samples, compromising their shape memory behavior, and unwanted contribution of 
moisture mass when weighing out thermoplastic samples can negatively affect the 
stoichiometry of reactions. 
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Figure 6 Dip coated pin after processing. The polymer is currently a semi-soft gel due to residual solvent. 
Post curing removes this residual solvent and yields the final material. The clarity of the material at the tip 
of the pin is indicative of favorable miscibility. 
 
 
 
Sol/gel analysis 
Sol/gel analysis experiments were conducted to quantify the amount of potentially 
leachable components left within the final stent material. These leachables are important 
to consider for material biocompatibility. Five vials were filled with approximately 50 
mg of stent pieces and dried under vacuum at 80°C for 24 hours. After drying, the 
polymer mass was recorded and THF was added to the vial to yield a 1:150 polymer to 
THF ratio. The vials were oscillated at 50°C for 24 hours. The swollen stent samples 
were removed from solution, transferred to new vials, and dried under vacuum at 80°C 
for 24 hours. The final polymer masses were recorded and the gel fraction was 
quantified according to the following equation: 
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   (1) !"#  !"#$%&'( = !!!! 
Where wf is the final sample weight, and wo is the initial sample weight. 
 
Three point bend tests 
To quantify their ability to navigate tortuous vessels, stent prototypes with varying wall 
thicknesses were tested for their longitudinal flexibility using a TA Q800 Dynamic 
Mechanical Analyzer in the 3 point bending mode. The stents were tested at room 
temperature (23 °C) for comparison to other published data24, and at 37°C to analyze the 
performance of the device at body temperature. The expanded devices were held at the 
testing temperature for five minutes to reach thermal equilibrium. The 4 mm diameter 
devices were bent to a displacement of 1.2 mm at a rate of 5 mm/min, and then returned 
back to zero displacement at the same rate. This method was adapted from the ASTM 
F206-08 standard for testing stents and stent systems26 with modifications to 
accommodate the geometry of the DMA three point bending fixture. The ASTM 
standard calls for a 2 mm displacement, but displacements beyond 1.2 mm caused the 
sample to hit a lower portion of the three point bending base, effectively reducing the 
span length from 20 mm to 13 mm. The span length was set to 20 mm to more 
accurately reproduce the method used by Ormiston et al.24. Longitudinal flexibility was 
determined by plotting static force versus displacement and interpolating the slope of the 
initial loading curve. 
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Radial force and recovery tests 
These tests were conducted using a Blockwise RJA62 J-Crimp™ Radial Compression 
Station coupled to an Instron 5965 tests frame. The components of this system are 
outlined in figure 7. This system transduces the linear motion, the force of which can be 
measured by the load cell, of the tensile tester into radial expansion and compression on 
the specimen. 
 
 
Figure 7 The left panel shows the full experimental setup for the radial force experiments. The tensile 
testing frame (A) is connected via the tensile adapter rod (B) to the compression station (D). Temperature 
is controlled with the controller (C) and monitored in real time with a thermocouple (E) placed 
concentrically in the compression station. The right panel is a close-up of the nine compression dies. 
 
 
 
The mechanical relationship between the radial and linear behavior of this system can be 
defined by the following equations, which were provided by the device manufacturer: 
   (2)  ∆! = 0.7374 ∙ ∆! 
   (3)  !"# = 2.712 ∙ ! 
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   (4)  ! = !"#.!"∙!"#!∙!∙!  
Where ∆D is the change is sample diameter; ∆X is the movement of the tensile tester 
crosshead; TRF is the total radial force that the sample exerts on the nine dies of the 
crimping station; F is the force measured by the testing frame; P is the pressure exerted 
on the sample in pounds per square inch (PSI); D is the diameter of the sample; and L is 
the length of the sample. 
 
Crimping force and controlled expansion tests 
Stent prototypes were placed in the compression station and equilibrated to the testing 
temperature of 55˚C or 70˚C for one hour. Each sample was crimped from the initial, 
open diameter of ~4 mm to a final diameter of 1.4 mm over a period of one minute. The 
crimp was held for thirty seconds to let the material equilibrate if it is substantially 
visco-elastic. The crimping station was opened back to the original diameter over a 
period of one minute to match the loading profile.  The crimping and radial expansion 
behaviors of these devices were quantified by plotting pressure as a function of crimping 
percentage, which is defined by the following equation: 
   (5) !"#$%% =    !!!!!!!!.!   !  100 
Where ϕ o is the original stent diameter, and ϕ is the current stent diameter. This 
measurement is a quantification of the crimp amount, with a 1.4 mm final diameter 
being 100% crimped. This is not a quantification of the percent reduction in overall 
device diameter. Stents with wall thicknesses of 140, 180, and 220 microns were tested 
at Tg (55˚C) and 70˚C. It is useful to know the crimping behavior at 55˚C because it is 
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the tan delta peak, which is the temperature for theoretical max strain. Recovery 
behavior at 70˚C will be useful to know because this temperature is within the rubbery 
plateau of the material, indicating full shape recovery.  
 
Constrained radial recovery 
Polymer tubes with 4.26 ± 0.02 mm diameters, 5.85 ± 0.01 mm lengths, and 150 micron 
thicknesses were crimped using a Machine Solutions Inc. SC 150 stent crimping station. 
The tubes were loaded in the crimping head and equilibrated at Tg for one hour. The 
stents were crimped to a final diameter of 1.4 mm using a gauge pin. To fix the 
temporary shape, the crimping head was held fixed and cooled to room temperature over 
a period of two hours. The tubes were removed from the crimping station and placed 
into the Blockwise compression station tensile adapter at room temperature. The 
compression station diameter was set to a specific crimping percentage according to the 
following equation: 
   (6) !!"#! = !! − (!! − 1.4) ∙ !"#$%%!""  
Where ϕ test is the station diameter during the test. Temperature was ramped from room 
temperature to 70˚C in order to measure the recovery force of the tubes through the full 
glass transition and into the rubbery plateau of the material. Temperature was sampled 
every 10 seconds using a stopwatch and a thermocouple placed concentrically within the 
compression station. The thermocouple was necessary because this system is designed 
for equilibrated temperature testing, and there is a significant difference (10-15 degrees) 
between the controller readout and the actual temperature of the compression dies during 
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portions of the heating profile. Constrained recovery was quantified by plotting pressure 
vs. temperature of tubes recovering to 100, 80, 60, 40, and 20 crimping percent. All tests 
were run at least twice to verify the repeatability. 
 
Stent shape recovery 
Stent prototypes were crimped over a wire using the same method described above in the 
constrained recovery tests. The crimped stent was placed in a water bath at 70˚C and the 
shape recovery was filmed using a digital camera. 
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CHAPTER III 
RESULTS 
   
Thermoplastic polymer syntheses 
Table 2 outlines the Size Exclusion Cromatography results of the synthesized 
thermoplastic polymers. Results are given as number average molecular weight (Mn), 
weight average molecular weight (Mw), and polydispersity index (PDI), which is the 
ratio of the two (Mw/Mn).  
 
TABLE 2 
Thermoplastic Polymer SEC Results 
%	  Allyl	  
Alcohol	   Mn	  (g/mol)	   Mw	  (g/mol)	   PDI	  
0	   97600	   221400	   2.27	  
1	   63500	   131000	   2.06	  
3	   36600	   61900	   1.69	  
5	   29500	   50800	   1.72	  
 
 
Increasing allyl alcohol content shows clear a trend in lowering polymer molecular 
weight. Smaller polymer chains are more soluble in solvent, and should be more 
miscible in solution with the proprietary crosslinkers. Additionally, increasing allyl 
alcohol content results in a narrower polydispersity index (PDI). This means the polymer 
chains are becoming more consistent in length, which could result in a more 
homogenous polymer network after crosslinking. A more homogeneous network results 
in a narrower glass transition and thus, faster device recovery. 
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Thermoset films 
Crosslinker A (f =4) and Crosslinker B (f=3) were selected in accordance with the work 
done by Keith Hearon. Phase separation of crosslinkers from the thermoplastic blends 
occurred during solution casting and increased with increasing thermoplastic molecular 
weight and increasing crosslinker composition.  Samples without phase separation were 
achievable for samples with Mw < 100 kDa and with crosslinker compositions ≤  50%.  
During phase separation, precipitation of the solution blended crosslinkers occurs, 
resulting in a lower stoichiometric ratio of crosslinker reactive sites : C=C groups than 
desired.  Consequently, the phase separated samples have lower crosslink densities and 
altered mechanical properties.  The two approaches for reducing phase separation were 
lowering the thermoplastic polymer molecular weight (described in the previous section) 
and reducing the molar content of the crosslinker. The polymers outlined in Table 1 were 
visually inspected for optical clarity.  For the purpose of this study, samples with 
complete optical clarity as observed by close inspection by the naked eye were 
determined to have no phase separation. The clear samples with the highest molecular 
weight and crosslinker content were series 3B, the 5% allyl alcohol, 50% Crosslinker A 
composition. This composition was chosen for more quantitative mechanical analysis. 
Although Crosslinker B compositions yielded clear films when blended in up to 80% 
composition with 5% AA thermoplastics, this crosslinker was not selected because it 
was highly light sensitive. Since dip-coating can take several hours, a light sensitive 
crosslinker is not ideal for the proposed stent processing technique. 
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Dynamic mechanical analysis (DMA) 
DMA experiments were performed on dip-coated and thicker solution cast films of the 
selected composition. Dip-coated films were ~120-200 microns thick, while the solution 
cast films were ~900-1200 microns thick.  Figure 8 presents differences in the storage 
moduli and tan delta of the materials prepared by dip-coating or solution casting. The 
solution cast films exhibited a broader tan delta peak and a higher rubbery modulus than 
those of the dip coated films. 
 
 
Figure 8 DMA results for dip-coated and solution cast films. (A) The broader tan delta peak of the 
solution cast sample indicates that this sample had less network homogeneity than the dip-coated sample. 
(B) The solution cast films exhibited a 50% higher rubber modulus value when compared to the dip-coated 
films. 
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The breadth of the glass transition region of a polymer is indicative of network 
homogeneity.  Glass transition breadth can be measured by the sharpness of the tan delta 
peak, which is determined by DMA testing and is often quantified in the literature by 
calculating the full width half maximum (FWHM) value of a tan delta peak27. With a 
FWHM value of 12.6 ˚C, the dip-coated films demonstrate substantially higher network 
homogeneity when compared to solution cast films with a FWHM of 26.9 ˚C. For many 
SMP applications, sharp glass transitions are desirable because the SMP remains glassy 
until it is heated to a temperature very close to its Tg, thus enabling high degrees of 
shape fixity until heating to a desired, specific actuation temperature. By this 
qualification, the DMA results indicate that the dip-coated samples are more desirable 
for a stent application than the solution cast films. The 50% higher rubbery modulus of 
the solution cast films allows for greater device recovery force, but this comes with the 
trade off of less strain to failure. Since crimping strains are already limited by thicker 
strut cross sections, a lower rubbery modulus could be advantageous in the case of this 
stent application. Based on the thermal history and preparation techniques of these 
samples, it is assumed that the dip-coated films are more representative of the stent 
material. Although these two samples are different thicknesses (Dip coated films ~ 150 
microns, Solution cast ~ 1000 micron), these DMA tests are geometry independent and 
take the size of the sample cross section into account.  
 
The reasons for the observed differences in dynamic moduli for the dip-coated versus 
solution cast samples are not fully understood at the present time, but they are being 
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investigated as part of a future publication for these materials. Preliminary results 
indicate that residual solvent content during crosslinking likely affects the crosslinking 
reaction kinetics; however, these considerations are beyond the scope of this study. 
The tan delta peak temperature of 55˚C will be used as the Tg of the materials for this 
study. Since this Tg is above body temperature, these devices would require an external 
heating source for actuation. 
 
Strain to failure 
Strain to failure tests were conducted on dog bone samples at the tan delta peak 
temperature of 55ºC to determine the maximum strain capability of these materials. The 
data in figure 9 gives insight into the maximum deformation a device can undergo 
during crimping before the device fails. The average ultimate strain of the material is 
1.16 ± 0.09, and average ultimate stress is 10.34 ± 0.85 MPa. 
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Figure 9 Strain to failure results at 55˚C. The different curves are duplicates of the same test to show 
repeatability. Average ultimate strain is 1.16 ± 0.09 and average ultimate stress is 10.34 ± 0.85 MPa. 
 
 
 
To get a first order approximation of the crimping strains experienced by the device, the 
equation for beam bending strain can be applied: 
   (7) ! =    !! 
Where ! is the bending strain, y is the distance from the neutral axis, and r is the radius 
of curvature. The maximum tensile strain a crimped stent would undergo would be along 
the edges of a complete fold. A completely folded 220 micron tube would have a 220 
micron radius of curvature, with the exterior edge (y = 110 microns) undergoing the 
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maximum strain. This situation yields a bending strain of 0.50, which is well within the 
material strain limit of 1.16. Crimping trials have proven that stents made of this 
material consistently crimp at 55°C without cracks or creases. 
 
Stent prototypes 
The final stent prototypes measured 25.51 ± 0.32 mm long and 4.29 ± 0.05mm in 
exterior diameter with wall thicknesses ranging from 140 to 220 microns depending on 
the number of dips (6-10 dips). However, control over thickness is relative to each round 
of dip-coating. Although this preparation technique consistently results in functional 
devices, it needs further optimization for more consistent thickness control.  The primary 
problem for thickness control is solvent evaporation from the dip-coating solution, 
which changes the concentration and viscosity during the lengthy process. The laser-
machined edges of the prototypes appear rough when observed under SEM (see bottom 
of the figure found on p. 34). These rough edges provide nucleation points for device 
failure at high strain, and provide more surface area for protein adhesion and biofouling. 
However, higher quality laser machining systems, such as an excimer laser, could be 
used to improve the edge quality of the stents. Figure 10 shows the device design and 
demonstrates the crimpability of the device. The design uses five rings connected by “s” 
shaped struts. The rings hold the vessel open, while the strut design allows for overall 
stent flexibility18. Figure 11 shows the device in closer detail. 
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Figure 10 Images of a stent prototype with a 210 micron wall thickness in its (A) expanded state and (B) 
crimped state. Polymer opacity is due to residual Teflon from the dip-coating pin. 
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Figure 11 Scanning electron images of a stent prototype. The bottom panel is a close-up of a strut and 
shows the quality of the CO2 laser cut. 
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Sol/gel analysis 
The purpose of this gel fraction test was to quantify the amount of potentially leachable 
material still left within the crosslinked polymer. The gel fraction data is outlined in 
Table 3. The mass loss is likely due to uncrosslinked thermoplastic polymer chains, 
residual crosslinker, and photoinitiator that can escape the polymer network. 
 
TABLE 3 
Polymer Stent Gel Fraction Results (Average 0.92 ± 0.02) 
Wo	  (mg)	   Wf	  (mg)	   Gel	  Fraction	  
47.8	   43.9	   0.92	  
48.8	   44.5	   0.91	  
52.8	   48.4	   0.92	  
53.5	   51.6	   0.96	  
44.6	   42.1	   0.94	  
 
 
 
With an average gel fraction of 0.92, this material could leach a considerable amount of 
material during the device lifetime. The identity and biocompatibility of this 
uncrosslinked material is not currently known, but it could possibly be detrimental to the 
body. However, changes to the fabrication and synthesis procedures can be made to get 
this gel fraction closer to the ideal value of 1.00. The gel fraction could be raised by 
using less photoinitiator (such as 1%), but only if the material properties are not 
significantly affected. Longer crosslinking and post cure times could also raise the gel 
fraction by ensuring more complete material reaction. Another approach would be to 
remove the leachables prior to device implantation via solvent swelling.   
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Three point bending 
Figure 12 shows a clear trend that longitudinal stiffness increases with increasing wall 
thickness. Additionally, these devices have longitudinal stiffness values below or within 
the lower range of the stents reported by Ormiston et al24. This reference publication 
conducted 3 point bend analysis on devices with a diameter of 3.5mm, which is 0.5mm 
less than the devices in this study. This is an important note because diameter has a 
definite affect on longitudinal flexibility. In spite of this difference in diameter, the 
stiffness data in figure 12 shows that these devices could have potential in applications 
involving highly tortuous vasculature, such as in the brain. Figure 12 also shows that 
there is only a small difference between the room temperature and body temperature 
stiffness values, which is to be expected since the material is still in its glassy state at 
body temperature. The horizontal error bars are the average and standard deviations of 
stent wall thickness based on 5 measurements at each end of the stent. These bars are 
large because the material gets thicker along the length of the dip-coating pin due to the 
nature of the dip. A longer dip would provide a longer region of homogenous thickness, 
but the 51mm length of the dip-coating stage inhibits this. The thickness is more uniform 
when the sample is machined out of the middle of the dip, but this minimized the useable 
material for the study and was not always followed due to the need for more samples. 
There is no data point for the 220 micron devices at body temperature because all of the 
devices of this dimension were damaged in other tests, and the deadline of this study 
inhibited the fabrication of more devices to complete the figure. 
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Figure 12 Three point bending results show increased longitudinal stiffness with increasing stent wall 
thickness. These devices exhibit longitudinal stiffness values below or within the lower range of currently 
available stent systems24.  Vertical error bars are ranges (n=3) while horizontal bars are standard 
deviations computed from 5 measurements at either end of the stent. 
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Tensile shape memory tests 
These tests were not successful. Ideally the samples for these tests would be ~1mm in 
thickness. It is possible to get this thickness by solution casting films, but as discussed in 
previous sections, the kinetics of the current solution casting method yields samples with 
mechanical properties that differ from the dip-coated material. Although dip-coated 
films had the desired mechanical properties, they were too thin for these tests to get 
consistent results. 
 
Free recovery tests 
These tests ran smoothly until the free recovery step. During material recovery, the video 
extensometer would lose correlation with the sample due to curling. This curling is 
likely due to minor temperature variations within the thermal chamber during heating. 
The samples are especially sensitive to minor temperature fluctuations because of their 
thin geometry. This curling effect could be minimized by thicker samples because a 
bigger cross section will resist out of plane bending, resulting in a more linear shape 
recovery that can be detected by the video extensometer. 
  
Constrained recovery tests 
A few constrained recovery tests were successful, but the material was only strained to 
10%. Although this material can definitely withstand higher strains (according to figure 
9), these tests were not pursued further due to time limitations. These tests were intended 
for future constitutive model calibration, but constrained recovery data is not useful 
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without complementary free recovery data. These tests will be possible once a consistent 
method for casting thicker films is created. 
 
Stent recovery 
As seen in figure 13, these devices display excellent shape recovery. A crimped stent 
fully recovers within one second when submerged in a 70˚C water bath. This quick 
deployment time will make it easy for physicians to hold the device in the correct place 
during device actuation. A fast delivery time also reduces the total amount of heat 
introduced into the neurovascular environment, which minimizes the potential for 
thermal tissue damage. A one second deployment time is an order of magnitude faster 
than other proposed stent systems deployed at body temperature with recovery times 
ranging from 10 seconds4, 7 to 150 seconds22. Although this polymer system used in this 
study can be tailored to have a Tg around body temperature, ambient body heat actuation 
can cause device failure if the device deploys prematurely in the catheter, causing it to 
stick. Although a higher temperature deployment complicates the final device with a 
heating apparatus, it gives the clinician an additional level of control and increases the 
device working time.  
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Figure 13 Time-lapse figure showing a recovering stent in a 70˚C water bath. Full recovery took place 
within one second. 
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Crimping force and controlled expansion 
Figure 14 outlines the typical crimping and unloading behavior of the stent prototypes at 
a fixed temperature. 
 
 
Figure 14 Breakdown of stent crimping and unloading behavior. Labeled regions of the curve match the 
corresponding crimp picture below. Pressure increases during star formation and drops after material 
buckling. Pressure starts to increase again when the stent doubles over multiple times. 
 
 
The top portion of the figure shows stent mechanical behavior, while the labeled pictures 
below show tube crimping profiles to give a representative view of the device geometry. 
The red portion of the curve indicates material loading during the crimp. There is an 
increase in stress from points A to B as the circular stent cross section takes on a nine 
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pointed star pattern. At point C, there is a decrease in stress as one of the star points 
buckles into the interior. There is a complete reduction in stress due to extensive 
buckling at point D. It is important to note that this zero-stress portion typically occurs 
between 40-55 crimp percent. These crimp percentage values will show interesting 
behavior during device recovery, which is to be presented in future sections. This 
buckling behavior, which does not occur in a completely repeatable manner, can be 
problematic for predicting the stress and geometry of the material during crimping. At 
point E the stress begins to rise again until the ultimate crimping pressure is reached. 
Crimping pressure is analogous to collapse pressure, but not the same. This crimping 
pressure is useful to understand the device fabrication process, but the mechanics of the 
crimping station are vastly different from a collapsing blood vessel. The compression 
station value is a pressure in that it is a force per unit area, but it is not the same as a 
pressure gradient between the interior and exterior of a compliant tube. A collapsing 
vessel flattens when exposed to an external pressure, rather than folding into an 
organized crimp. Thus, this crimping pressure cannot be referred to as the collapse 
pressure, which is a more physiologically relevant value. The orange portion of the curve 
shows stress relaxation when the crimp is held constant.  
 
Figure 15 is the exact same loading cycle as figure 14, but shown as a function of time. 
The orange stress relaxation portion is easier to see in this time dependent figure. This 
stress relaxation is due to the visco-elastic nature of the polymer and is likely dependent 
on the crimping rate. The blue portions of each figure show the force exerted by the 
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material while the compression station is opened back to the original diameter. 
According to this curve, there is a negligible amount of force being exerted by the 
material below ~70 crimp percent. However, additional tests will prove this to be 
inaccurate. It is suspected that the crimping station is opening too fast for the sample to 
recover to its maximum force at 55˚C.   
 
 
Figure 15 Stress relaxation is more apparent in this time dependent curve. This is the same data set as the 
curve breakdown in figure 14. 
 
 
 
Figure 16 shows a comparative increase in crimping pressure and recovery pressure with 
increasing stent wall thickness. Sufficient wall thickness is important to have enough 
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radial force to keep the vessel open, but stent struts that are too thick can impede blood 
flow and negatively disrupt the flow profile. 
 
 
Figure 16 Comparison of crimping force and recovery behavior of stents with increasing wall thickness. 
There is a clear trend in increasing crimping pressure with increasing wall thickness. 
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Figure 17 Comparison of stent crimping at T = Tg and T > Tg. Pressure values are lower at higher 
temperature because the material is in its rubbery state. The less homogeneous shape of the high 
temperature curve is being attributed to material failure during the crimping process. 
 
 
 
Figure 17 shows crimping profiles of 180 micron thick stents at Tg (55˚C) and 15 
degrees above Tg when the material is within the rubbery plateau. As expected, the 
higher temperature curve exhibited lower radial forces due to the material being more 
rubbery. Additionally, all stents that were crimped at 70˚C showed creasing and 
breaking after crimping and subsequent recovery. Thus, these devices should not be 
crimped above Tg because the material may not be tough enough to withstand the 
crimping strains. The 70˚C curve is much less smooth when compared to the 55˚C curve, 
and it is proposed that the bumps are associated with material failure during the crimping 
process at higher temperatures. 
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Constrained radial recovery 
Figure 18 shows the behavior of polymer tubes when deployed into a fixed diameter 
environment, similar to deploying within an occluded vessel. These rings are 
idealizations of the overall stent, representing the rings within the stent design. These 
tests quantify how much pressure the device can exert as a function of temperature. 
 
 
Figure 18 Constrained tube pressure recovery as a function of temperature. The resulting geometries for 
each crimp percentage are depicted below the curve. The 40% curve does not follow the expected trend, 
highlighting the fact that these recovery pressures are highly dependent on the crimp geometry. 
 
 
The data from figure 18 is more representative of device in vivo recovery than that 
presented in figures 14-17 because deployment in a vessel is a constrained recovery 
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environment. These curves have a wavy appearance before reaching an eventual plateau 
due to unfolding and sudden changes in the recovering geometry until a stable shape is 
reached. There is a trend with decreasing recovery pressure with decreasing crimp%. 
However, the 40 crimp% does not follow this trend because it registers pressures below 
the 20 crimp%. This behavior can be linked back to the crimping behavior explained in 
figure 14. The crimp percentages associated with part D of the curve show that no stress 
is exerted radially due to buckling. These same geometry conditions seem to be 
contributing to the constrained recovery force. A stress cannot be recovered unless it is 
“programmed” into the material. This behavior will need to be considered in the clinical 
application of this device. It will be important to have a way to verify that the device 
deploys beyond a 40 crimping percent in vivo. Also, the pressures exerted by the device 
are not sufficient enough to clear an atherosclerotic plaque, so it will most likely need to 
be deployed in conjunction with a balloon angioplasty. Although this complicates the 
delivery procedure, low device pressures at full expansion will minimize the force 
exerted on the diseased vessel wall. This is an advantage because these tissues can be 
mechanically compromised and prone to rupture. 
 
Future work 
Computational models can be powerful tools for streamlining the design process of 
medical devices. Finite element analysis is employed in the design of traditional nitinol 
stents28, 29, and a constitutive model of nitinol has been employed to optimize the design 
of a braided stent30. However, constitutive modeling of SMPs is much less prevalent in 
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the design of stents. A constitutive model of these shape memory materials implemented 
in 3D can be a powerful tool for optimizing medical devices, but it is important to 
validate the developed model with multi-axial experimental data. Even if the constitutive 
model is calibrated according to one-dimensional tensile data, it is still important to get 
physical multidimensional characterization to validate the efficacy of the full 
computational model. Finite element analysis has been performed on a shape memory 
polymer polyurethane stent prototype31, but the results of the model were not validated 
with experimental data. 
 
The radial crimping and expansion data from this thesis could be used for an initial 
validation of a multidimensional computational model of shape memory polymers. The 
constrained tube recovery tests will be ideal for validation purposes because they involve 
a simplified geometry that enables straightforward modeling. However, the complex 
geometric considerations involved with device crimping and uncrimping will complicate 
the model beyond characterizing the material shape memory behavior. Once the 
constitutive model is validated, it can be used to simulate and optimize a more complex 
stent design and other medical devices.  
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CHAPTER IV 
SUMMARY AND CONCLUSIONS 
 
This study expanded on the clinical efficacy of a previously proposed stent design by 
quantifying the longitudinal flexibility, shape memory abilities, gel fraction, and 
expansion pressures of the device. With longitudinal stiffness values comparable to 
flexible devices available on the market, these devices show promise in neurovascular 
applications requiring increased compliance to deploy in tortuous vessels. The excellent 
shape memory of these materials allows the device to deploy in one second. This rapid 
deployment allows for controlled device delivery, and reduces the amount of heat 
introduced into the vascular environment. Although the expansion pressures produced by 
these devices are not sufficient to clear an atherosclerotic plaque, low expansion 
pressures reduce the risk of rupturing a mechanically compromised diseased vessel wall.  
 
The thermo-mechanical characterization of these devices, such as recovery pressures and 
optimal crimping techniques, provides data relevant to the clinical implementation of the 
device design. This data could also be used as an initial validation of a thermo-
mechanical computational model. An accurate model would be helpful in the design and 
optimization of novel SMP biomedical devices including stents and thrombectomy 
devices. However, this data is not detailed enough to stand alone as the computational 
model validation. The unpredictable geometric changes during the crimping and 
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uncrimping process have shown that this device is not the best candidate for validating 
an intensive computational model.  
 
Although this polymer system currently does not have all of the properties desirable of 
an optimized stent, it provides a solid platform for development of a fully functional 
device. The proposed composition displays mechanical properties desirable for stent 
applications. Future improvements for this polymer system include making it 
biodegradable, increasing the gel fraction to reduce potentially leachable material, and 
making it radio-opaque. It will also be necessary to quantify the biocompatibility of 
these polymers. 
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